BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2922791)

  • 1. The effect of additives on red cell 2,3 diphosphoglycerate levels in CPDA preservatives.
    Vora S; West C; Beutler E
    Transfusion; 1989; 29(3):226-9. PubMed ID: 2922791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxalate and malonate on red cell metabolism.
    Beutler E; Forman L; West C
    Blood; 1987 Nov; 70(5):1389-93. PubMed ID: 2822172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic manipulation of key glycolytic enzymes: a novel proposal for the maintenance of red cell 2,3-DPG and ATP levels during storage.
    Vora S
    Biomed Biochim Acta; 1987; 46(2-3):S285-9. PubMed ID: 3593307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells.
    Heaton A; Keegan T; Holme S
    Br J Haematol; 1989 Jan; 71(1):131-6. PubMed ID: 2492818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell ATP and 2,3-diphosphoglycerate concentrations as a function of dihydroxyacetone supplementation of CPD adenine.
    Moore GL; Ledford ME; Brummell MR
    Vox Sang; 1981; 41(1):11-7. PubMed ID: 7324438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adenosine triphosphate and 2,3-diphosphoglycerate after twenty-four hours in red cells washed for neonatal transfusion.
    Wrotnowski U; Gray LS; Anderson G; Samsell JE; Mintz PD
    Vox Sang; 1988; 54(2):71-3. PubMed ID: 3376466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
    Jeter EK; Gadsden RH; Cate J
    Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
    Moore GL; Ledford ME; Unruh KA; Brummell MR
    Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic aspects and viability of heparin/CPDA-1-stored red cell concentrate as a by-product of a high-yield factor VIII production method.
    de Jonge J; Smit Sibinga CT; Das PC
    Haemostasis; 1983; 13(4):214-8. PubMed ID: 6413307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthone additives for blood storage that maintain its potential for oxygen delivery. I. 2-Hydroxyethoxy- and 2-ethoxy-6-(5-tetrazoyl) xanthones in citrate-phosphate-dextrose-adenine (CPDA-1) blood.
    Paterson RA; Dawson J; Hyde RM; Livingstone DJ; Parry ES; Nash S; Boyce IM
    Transfusion; 1988; 28(1):34-7. PubMed ID: 3341063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
    Beutler E; West C
    J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved red blood cell storage using optional additive systems (OAS) containing adenine, glucose and ascorbate-2-phosphate.
    Moore GL; Ledford ME; Brummell MR
    Transfusion; 1981; 21(6):723-31. PubMed ID: 7314223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
    Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
    Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood preservation. XXIX. Pyruvate maintains normal red cell 2,3-DPG for six weeks of storage in CPD-adenine.
    Dawson RB; Hershey RT; Myers CS
    Transfusion; 1980; 20(2):218-23. PubMed ID: 7368270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood storage XXII. Improvement in red blood cell 2,3-DPG levels at six weeks by 20 mM PO4 in CPD-adenine-inosine.
    Dawson RB
    Transfusion; 1976; 16(5):450-4. PubMed ID: 982537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
    Moore GL; Ledford ME; Peck CC
    Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.